Evidence map›Paper›PMID 32591586›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence.

Marta Abengozar-Muela, María Villalba Esparza, David Garcia-Ros, Cindy Estefanía Vásquez, José I Echeveste, Miguel Angel Idoate, Maria D Lozano, Ignacio Melero, Carlos E de Andrea

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Building Spatiotemporal Understanding ofACS infectious diseases · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Marta Abengozar-MuelaDepartment of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
María Villalba EsparzaDepartment of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
David Garcia-RosDepartment of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Cindy Estefanía VásquezDepartment of Anatomy, Physiology and Pathology, University of Navarra, Pamplona, Spain.
José I EchevesteDepartment of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Miguel Angel IdoateDepartment of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Maria D LozanoDepartment of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
Ignacio Melero *Navarra Institute for Health Research (IDISNA), Pamplona, Spain.
Carlos E de Andrea *Department of Pathology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain. ceandrea@unav.es.
Clinica Universidad de Navarra · ESNavarre Institute of Health Research · ESCentro de Investigación Biomédica en Red de Cáncer · ESUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The precise nature of the local immune responses in lung tuberculosis (TB) granulomas requires a comprehensive understanding of their environmental complexities. At its most basic level, a granuloma is a compact, organized immune aggregate of macrophages surrounded by myeloid, B and T cells. We established two complementary multiplex immunolabeling panels to simultaneously evaluate the myeloid and lymphocytic contexture of 14 human lung TB granulomas in formalin-fixed paraffin-embedded tissue samples. We observed diverse CD3+ and CD8+ T-cell and CD20+ B lymphocyte compositions of the granuloma immune environment and a relatively homogeneous distribution of all myeloid cells. We also found significant associations between CD8+ T-cell densities and the myeloid marker CD11b and phagocytic cell marker CD68. In addition, significantly more CD68+ macrophages and CD8+ T cells were found in Mycobacterium tuberculosis-infected granulomas, as detected by Ziehl-Neelsen staining. FOXP3 expression was predominately found in a small subset of CD4+ T cells in different granulomas. As the success or failure of each granuloma is determined by the immune response within that granuloma at a local and not a systemic level, we attempted to identify the presence of reactive T cells based on expression of the T-cell activation marker CD137 (4-1BB) and programmed cell death-1 (PD-1). Only a small fraction of the CD4+ and CD8+ T cells expressed PD-1. CD137 expression was found only in a very small fraction of the CD4+ T cells in two granulomas. Our results also showed that multinucleated giant cells showed strong PD-L1 but not CTLA-4 membrane staining. This study offers new insights into the heterogeneity of immune cell infiltration in lung TB granulomas, suggesting that each TB granuloma represents a unique immune environment that might be independently influenced by the local adaptive immune response, bacterial state, and overall host disease status.

Indexed as

Adaptive ImmunityFluorescent Antibody TechniqueImmunophenotypingAdultAgedBiomarkersCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCellular MicroenvironmentGranulomaHost-Pathogen InteractionsHumansLungMaleMicroscopy, FluorescenceMiddle AgedBiomarkers

Identifiers

PMID32591586
OpenAlexW3037465984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.